Compile Data Set for Download or QSAR
Report error Found 78 Enz. Inhib. hit(s) with all data for entry = 9633
TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477131BDBM477131(US10888567, Compound 42 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477158BDBM477158(US10888567, Compound 67 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477156BDBM477156(US10888567, Compound 66 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477136BDBM477136(US10888567, Compound 47 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477107BDBM477107(US10888567, Compound 3 | US11414428, Compound 1 | ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477105BDBM477105(US10888567, Compound 1 | US20250186410, Compound 1)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477122BDBM477122(US10888567, Compound 16 | US20250186410, Compound ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477138BDBM477138(US10888567, Compound 49 | US20250186410, Compound ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477116BDBM477116(US10888567, Compound 11 | US20250186410, Compound ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477114BDBM477114(US10888567, Compound 9 | US20250186410, Compound 9)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477113BDBM477113(US10888567, Compound 8 | US20250186410, Compound 8)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477111BDBM477111(US10888567, Compound 6 | US20250186410, Compound 6)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477110BDBM477110(US10888567, Compound 5 | US20250186410, Compound 5)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477109BDBM477109(US10888567, Compound 4 | US20250186410, Compound 4)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477178BDBM477178(US10888567, Compound 84 | US20250186410, Compound ...)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477139BDBM477139(US10888567, Compound 50)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477171BDBM477171(US10888567, Compound 79)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477167BDBM477167(US10888567, Compound 75)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477166BDBM477166(US10888567, Compound 74 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477165BDBM477165(US10888567, Compound 73)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477164BDBM477164(US10888567, Compound 72)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477163BDBM477163(US10888567, Compound 71)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477162BDBM477162(US10888567, Compound 70)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477161BDBM477161(US10888567, Compound 69)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477159BDBM477159(US10888567, Compound 68)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477155BDBM477155(US10888567, Compound 65)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477153BDBM477153(US10888567, Compound 64)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477152BDBM477152(US10888567, Compound 63)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477151BDBM477151(US10888567, Compound 62)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477150BDBM477150(US10888567, Compound 61)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477149BDBM477149(US10888567, Compound 60)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477185BDBM477185(US10888567, Compound 91)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477184BDBM477184(US10888567, Compound 90)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477183BDBM477183(US10888567, Compound 89 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477182BDBM477182(US10888567, Compound 88)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477181BDBM477181(US10888567, Compound 87)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477180BDBM477180(US10888567, Compound 86)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477179BDBM477179(US10888567, Compound 85)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477177BDBM477177(US10888567, Compound 83)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477175BDBM477175(US10888567, Compound 82)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477174BDBM477174(US10888567, Compound 81)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477173BDBM477173(US10888567, Compound 80)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477170BDBM477170(US10888567, Compound 78)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477169BDBM477169(US10888567, Compound 77)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477168BDBM477168(US10888567, Compound 76)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477190BDBM477190(US10888567, Compound 96)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477189BDBM477189(US10888567, Compound 95 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477188BDBM477188(US10888567, Compound 94)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477187BDBM477187(US10888567, Compound 93)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477186BDBM477186(US10888567, Compound 92)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

Displayed 1 to 50 (of 78 total ) | Next | Last >>
Jump to: